Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico
Clinical trial NCT02112890 · COMPLETED
Trial details
- NCT number
- NCT02112890
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-12-10
- Primary completion
- 2016-05-02
- Enrollment
- 1603
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.